Bombay Super Hybrid Seeds Limited

NSE:BSHSL.NS

180.58 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Revenue 1,567.724301.154763.38337.5871,166.655357.8689.555210.2321,021.594296.706627.922171.812841.584282.078517.988176.332737.056192.068297.127104.159271.645155.701155.701217.322217.322115.868151.717270.288270.288
Cost of Revenue 1,368.008233.725563.418260.333968.314300.287562.769175.649873.867305.141534.547135.462680.956256.51472.943150.685649.048155.641263.54669.474236.334130.632130.632188.677188.67797.032123.102240.237240.237
Gross Profit 199.71667.429199.96277.254198.34157.513126.78634.583147.727-8.43593.37536.35160.62825.56845.04525.64788.00836.42733.58134.68535.31125.06825.06828.64528.64518.83628.61530.05130.051
Gross Profit Ratio 0.1270.2240.2620.2290.170.1610.1840.1640.145-0.0280.1490.2120.1910.0910.0870.1450.1190.190.1130.3330.130.1610.1610.1320.1320.1630.1890.1110.111
Reseach & Development Expenses 00000000018.19100013.3560009.7280004.0724.072003.3953.39500
General & Administrative Expenses 0000000001.932000136.18500010.7890006.5796.579005.828.3200
Selling & Marketing Expenses 0000000002.4660002.6260001.8150001.2891.289000.9670.55200
SG&A 67.73334.514111.58245.21563.99418.74936.01111.92453.2934.39839.74518.8983.563138.8115.185.2295.29312.6034.8926.4326.4327.8687.8687.0287.0286.7878.8726.2436.243
Other Expenses 0000.6710.3363.7212.1130.7090.327-1.3921.8692.940.8541.1230.8271.5830.902-3.7491.9420.98900000-0.8000
Operating Expenses 67.73334.514111.58251.76574.02527.82150.68623.73162.622-34.70664.35830.02597.5-0.51523.69122.0467.36123.56124.30330.0223.86815.5115.5120.9820.9810.01522.93121.6521.65
Operating Income 131.98332.91588.3826.159124.65333.41278.21411.56285.39226.16129.0176.32563.12826.08321.3543.60720.64712.8669.2784.66511.1079.439.437.027.028.8225.9158.1368.136
Operating Income Ratio 0.0840.1090.1160.0770.1070.0930.1130.0550.0840.0880.0460.0370.0750.0920.0410.020.0280.0670.0310.0450.0410.0610.0610.0320.0320.0760.0390.030.03
Total Other Income Expenses Net -12.696-7.018-8.515-8.804-12.514-13.806-7.279-1.922-7.261-10.585-1.4611.275-3.623-8.861-1.070.883-1.594-6.672-1.392-1.061-2.228-0.172-0.172-2.272-2.272-4.018-2.059-2.939-2.939
Income Before Tax 119.28725.89779.86517.355112.13919.60670.9359.6478.13115.57627.5567.659.50517.22220.2844.4919.0536.1947.8863.6048.889.2589.2584.7484.7484.8033.8565.1975.197
Income Before Tax Ratio 0.0760.0860.1050.0510.0960.0550.1030.0460.0760.0520.0440.0440.0710.0610.0390.0250.0260.0320.0270.0350.0330.0590.0590.0220.0220.0410.0250.0190.019
Income Tax Expense 8.091-5.42411.091.6515.7780.5284.414.591.7390.81.6271.033-3.9934.390.1824.6731.8261.72.0042.8612.3022.3021.2831.2832.4331.3661.7951.795
Net Income 111.19631.32168.77515.704106.36119.07866.5358.6473.56113.83726.7565.97358.47221.21615.8944.30814.384.3686.1861.66.0196.9566.9563.4653.4653.1072.493.4033.403
Net Income Ratio 0.0710.1040.090.0470.0910.0530.0960.0410.0720.0470.0430.0350.0690.0750.0310.0240.020.0230.0210.0150.0220.0450.0450.0160.0160.0270.0160.0130.013
EPS 1.060.290.660.151.010.190.630.0820.70.130.260.060.560.230.170.0460.180.0420.0870.0160.0590.0670.0670.0340.0340.030.0370.0630.063
EPS Diluted 1.060.290.660.151.010.190.630.0820.70.130.260.060.560.230.170.0460.180.0420.0870.0160.0590.0670.0670.0340.0340.030.0370.0630.063
EBITDA 135.78335.1492.1829.859128.35336.97381.71414.46288.89223.07735.38613.7668.33724.32225.9528.97125.21114.90813.7989.52114.97411.86111.1328.7228.7228.5797.35210.10410.104
EBITDA Ratio 0.0870.1170.1210.0880.110.1030.1190.0690.0870.0780.0560.080.0810.0860.050.0510.0340.0780.0460.0910.0550.0760.0710.040.040.0740.0480.0370.037